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Abstract. 
 
Rapamycin, an antifungal macrolide antibi-
 
otic, mimics starvation conditions in 
 
Saccharomyces
 
cerevisiae 
 
through activation of a general G
 
0
 
 program
that includes widespread effects on translation and
transcription. Macroautophagy, a catabolic membrane
trafﬁcking phenomenon, is a prominent part of this re-
sponse. Two views of the induction of autophagy may
be considered. In one, up-regulation of proteins in-
volved in autophagy causes its induction, implying that
autophagy is the result of a signal transduction mecha-
nism leading from Tor to the transcriptional and trans-
lational machinery. An alternative hypothesis postu-
lates the existence of a dedicated signal transduction
mechanism that induces autophagy directly. We tested
these possibilities by assaying the effects of cyclohex-
imide and speciﬁc mutations on the induction of au-
tophagy. We ﬁnd that induction of autophagy takes
place in the absence of de novo protein synthesis, in-
cluding that of speciﬁc autophagy-related proteins that
are up-regulated in response to rapamycin. We also
ﬁnd that dephosphorylation of Apg13p, a signal trans-
duction event that correlates with the onset of autoph-
agy, is also independent of new protein synthesis. Fi-
nally, our data indicate that autophagosomes that form
in the absence of protein synthesis are signiﬁcantly
smaller than normal, indicating a role for de novo pro-
tein synthesis in the regulation of autophagosome ex-
pansion. Our results deﬁne the existence of a signal
transduction-dependent nucleation step and a separate
autophagosome expansion step that together coordi-
nate autophagosome biogenesis.
Key words: autophagy • Tor • protein synthesis • vac-
uole • yeast
 
Introduction
 
Autophagy is a catabolic membrane trafficking phenome-
non that occurs upon starvation of yeast cells or upon ad-
ministration of rapamycin (Takeshige et al., 1992; Egner et
al., 1993; Noda and Ohsumi, 1998). In both cases, a signal
transduction cascade that involves the inactivation of the
Tor protein kinase plays a central role. During macroau-
tophagy, the form of autophagy commonly observed in
starved yeast cells, cytoplasmic material is sequestered in
double-membrane vesicles called autophagosomes (300–
900 nm diameter) and the autophagosomes fuse with the
lytic compartment, the vacuole, in a step that depends on
the vacuolar syntaxin, Vam3p (Darsow et al., 1997). Upon
fusion of the outer bilayer, vesicles called autophagic bod-
ies are released into the vacuolar lumen. These vesicles are
degraded, allowing vacuolar hydrolases access to the
cargo, thus recycling cellular building blocks (Baba et al.,
1994, 1997). While autophagy is induced only under spe-
cific conditions, salient mechanistic aspects of autophagy
are functional in a constitutive fashion. Induction of au-
tophagy subverts a constitutive membrane trafficking
mechanism called the cytoplasm to vacuole targeting
(Cvt)
 
1
 
 pathway from a specific mode, in which it carries
the resident vacuolar hydrolase, aminopeptidase I (API),
to a nonspecific bulk mode in which significant amounts of
cytoplasmic material are also sequestered and recycled in
the vacuole (Scott et al., 1996; Baba et al., 1997).
In the Cvt pathway a soluble cytoplasmic precursor
form of API (prAPI) is sequestered into double-mem-
brane vesicles called Cvt vesicles (140–160 nm) that are
analogous to, albeit smaller than, autophagosomes. Cvt
vesicles fuse with the vacuole in a Vam3p-dependent fash-
ion, releasing single-bilayer bound Cvt bodies into the vac-
uolar lumen, which in turn are degraded allowing the mat-
uration of prAPI (61 kD) to the mature form (50 kD) in a
proteinase B (PrB)-dependent fashion (reviewed in Klion-
sky and Ohsumi, 1999). Mutants have been isolated that
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are defective in the Cvt pathway and that accumulate
prAPI (Harding et al., 1995). These mutants were found to
overlap with the 
 
apg
 
 and 
 
aut
 
 mutants that were originally
identified as defective in yeast autophagy (Tsukada and
Ohsumi, 1993; Thumm et al., 1994; Harding et al., 1996;
Scott et al., 1996). A number of genes have also been iden-
tified that are required in Cvt trafficking but not for au-
tophagy. Cvt3p, Cvt9p (Harding et al., 1996), Cvt19p (S.V.
Scott and DJ. Klionsky, unpublished), Vac8p (Wang et al.,
1998; Scott et al., 2000), Tlg2p, and Vps45p (Abeliovich et
al., 1999) all appear to be proteins that are required for
normal aminopeptidase I trafficking but not for autoph-
agy. Whereas the biochemical roles of most of these pro-
teins in Cvt trafficking are not clear at present, the molec-
ular nature of Tlg2p and Vps45p sheds light on the
divergence of the two pathways. Tlg2p is a syntaxin homo-
logue (Abeliovich et al., 1998; Holthuis et al., 1998), and
Vps45p is a Sec1p homologue (Cowles et al., 1994) that
are found in a protein complex in cell extracts (Nichols et
al., 1998; Abeliovich et al., 1999). Mutations in either of
these genes result in the accumulation of membrane-
bound, unsequestered prAPI, implying a requirement for
specific membrane fusion events in the formation of the
Cvt vesicle. The fact that these proteins are not required in
autophagy, and that induction of autophagy altogether by-
passes the API trafficking defect of these mutants, sug-
gests that the sequestering membrane for autophagy dif-
fers from that used in the Cvt pathway, although the
sequestration mechanism itself may be very similar. Au-
tophagy in general is a nonspecific phenomenon, although
some cargoes appear to be selectively targeted, as happens
during pexophagy (Hutchins et al., 1999). Likewise, the ki-
netics and extent of rescue of the API block in cells that
overexpress API indicates that prAPI is sequestered by
autophagosomes in a specific mechanism (Scott et al.,
1996), again underscoring a similarity between the two
processes: the Cvt pathway and autophagy are alternative,
specific trafficking pathways for prAPI that function un-
der different metabolic conditions. Thus, the analysis of
API trafficking in a Cvt pathway-specific mutant allows us
to dissect events that occur during the induction of au-
tophagy.
The inhibition of the Tor1 and Tor2 protein kinases
leads to both G
 
1
 
 arrest and autophagy in yeast (Barbet et
al., 1996; Noda and Ohsumi, 1998; Zaragoza et al., 1998).
Recently, advances have been made regarding signal
transduction mechanisms that lie downstream of Tor, as
well as regarding the effects of Tor action on ribosomal
protein and RNA synthesis, and mRNA transcription. Tor
phosphorylates Tap42p, affecting its ability to interact
with protein phosphatase 2A (PP2A) catalytic subunits,
thus disrupting a balance between the association of these
catalytic PP2A subunits with a number of other regulatory
subunits that compete with Tap42p for binding to PP2A
(Di Como and Arndt, 1996; Jiang and Broach, 1999). The
end result is thought to be a change in activity level, local-
ization, or substrate specificity of PP2A. Changes in Tor
activity have dramatic effects on transcription (Zaragoza
et al., 1998; Cardenas et al., 1999; Hardwick et al., 1999)
and translation (Barbet et al., 1996; Powers and Walters,
1999). It has recently been shown that Tor activity pro-
motes the association of cytoplasmic sequestration factors
 
with a number of starvation-specific transcription factors,
preventing starvation-specific gene expression. In one
case, this effect was found to be mediated by a Tap42p-
and PP2A-related mechanism (Beck and Hall, 1999).
Transcription of rRNA and ribosomal protein genes is re-
pressed upon rapamycin treatment (Zaragoza et al., 1998;
Powers and Walters, 1999). Among known autophagy-
related genes, at least two, 
 
AUT7 
 
(also known as 
 
APG8
 
;
Hardwick et al., 1999; Kirisako et al., 1999; Huang et al.,
2000)
 
 
 
and 
 
APE1
 
(also known as 
 
LAP4
 
; Scott et al., 1996;
Hardwick et al., 1999), are upregulated by rapamycin treat-
ment and nitrogen starvation. Significantly, Aut7p is a com-
ponent of autophagosomes that is depleted by the autophagic
process: it is delivered into the vacuolar lumen and degraded.
Hypothetically, upregulation of specific proteins such as
Aut7p, coupled with other changes in gene expression,
might be a plausible mechanism for the induction of au-
tophagy during starvation or rapamycin treatment. In this
report, however, we show that such a mechanism cannot
account for the experimental facts. Complete inhibition of
protein synthesis by cycloheximide does not abolish the
bypass of the Cvt-specific API trafficking defect upon
treatment with rapamycin. Specifically, this bypass occurs
despite the fact that induction of Aut7p and API is abol-
ished under these conditions. Thus, the shift in membrane
trafficking pattern from Cvt-type trafficking to autophagy
involves a signaling pathway from Tor to effector mecha-
nisms that are independent of transcription and transla-
tion. We find that dephosphorylation of Apg13p, an event
that correlates with the onset of autophagy, also occurs in
the absence of protein synthesis. Finally, we demonstrate
that autophagosomes formed in the absence of protein
synthesis are aberrantly small. These data suggest the
functional dissection of autophagosome biogenesis into an
initial induction/nucleation step that directly depends on
signal transduction events and a secondary expansion step
that depends on de novo protein synthesis.
 
Materials and Methods
 
Materials
 
ECL reagents were from Amersham Pharmacia Biotech. HRP-conjugated
goat anti–rabbit antibodies were from Jackson ImmunoResearch Labora-
tories, Inc. Antiserum to Vac8p was a gift of Dr. Lois Weisman (Univer-
sity of Iowa, Iowa City, IA). Antisera to API (Klionsky et al., 1992) and
Apg13p (Scott et al., 2000) were previously described. Rapamycin and cy-
cloheximide were from Sigma-Aldrich. Expre
 
35
 
S
 
35
 
S protein labeling mix
was from Dupont-New England Nuclear Research Products. Immobilon-P
(polyvinylidene fluoride) was from Millipore Corp. Other reagents were
from Sigma-Aldrich or as indicated.
 
Strains, Media, Plasmids, and
Microbiological Techniques
 
The strains used in this study are listed in Table I. Strains were grown in
YPD medium (1% yeast extract, 2% peptone, 2% glucose) or synthetic
minimal medium (SMD; 0.67% yeast nitrogen base, 2% glucose, and auxo-
trophic amino acids and vitamins as needed). To make strains HAY394
and HAY382, plasmid pYW54 (containing 
 
vac8::TRP1
 
; gift of Dr. Lois
Weisman) was digested with AflII and EcoRI and transformed into
strains SEY6210 and TDY27, respectively. Disruption of the 
 
VAC8
 
 gene
was confirmed by immunoblotting. Strain HAY395 was constructed by
transforming strain SEY6210 with an 
 
apg1
 
D
 
::URA3
 
 (in pBluescript) con-
struct generously provided by Drs. Y. Ohsumi and Y. Kamada (National
Institute for Basic Biology, Okazaki, Japan). Plasmid YEp351[APG13] 
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was previously described (Scott et al., 2000). Yeast transformation was ac-
cording to Guthrie and Fink (1991).
 
Western Blot Analysis
 
Cells (10 A
 
600
 
 units) were grown to an A
 
600
 
 of 0.5–0.8 in SMD or YPD,
treated with 10% TCA and washed twice with acetone. The dry cell pellet
was then resuspended in 100-ml cracking buffer (50 mM Tris, pH 6.8,
3.6 M urea, 1 mM EDTA, 1% SDS) and vortexed in a TOMY MT-360
mixer at maximum speed with an equal volume of acid-washed glass
beads, for 15 min. Unlysed cells were removed by centrifugation and pro-
tein content was determined by bicinchoninic acid assay (Pierce Chemical
Co.) using BSA as standard. An equal volume of 2
 
3
 
 SDS loading buffer
was added and the samples were incubated at 70
 
8
 
C for 10 min. Equivalent
amounts of protein were loaded per lane.
 
In Vivo Labeling and Immunoprecipitation
 
Yeast cultures were grown to A
 
600
 
 of 0.5 in SD supplemented with the re-
quired amino acids. Cells (2 A
 
600
 
 units per time point) were harvested by
centrifugation at 1,800 
 
g
 
 and resuspended in 820 ml of SD medium with
amino acids. A 10-min pulse with 100 mCi 
 
35
 
S cysteine/methionine per
time point was followed by addition of chase solution (5 mM methionine
and 1 mM cysteine final concentration) and 100 
 
m
 
l cycloheximide solution
in SMD to a concentration of 40 
 
m
 
g/ml, or 100 
 
m
 
l SMD alone. After a fur-
ther 5-min incubation, the cells were diluted to a concentration of 2 A
 
600
 
U/ml in SMD with or without rapamycin. Final concentrations of rapamy-
cin and cycloheximide were 0.2 
 
m
 
g/ml and 10 
 
m
 
g/ml, respectively. Samples
were taken after dilution (time zero) and at indicated points thereafter,
and precipitated with 10% TCA. The samples were washed twice with
cold acetone, dried, and vortexed for 15 min with 100 
 
m
 
l cracking buffer
and an equal volume of glass beads. Samples were then incubated 10 min
at 70
 
8
 
C, diluted tenfold in IP dilution buffer (50 mM Tris, pH 7.5, 150 mM
NaCl, 0.5% Tween-20, 5 mM EDTA, and 100 
 
m
 
g/ml BSA) and centri-
fuged 5 min at 13,000 
 
g
 
. The supernatant was then precipitated overnight
with anti-API antibody (0.5 
 
m
 
l/2 A
 
600
 
 units cells) followed by a 2 hour in-
cubation with protein-A conjugated Sepharose (2% vol/vol final). Im-
mune complexes were then washed and processed for SDS-PAGE. Dried
gels were exposed to PhosphorImager plates and read on a STORM840
PhosphorImager (Molecular Dynamics) using ImageQuant 5.0 software.
 
Electron Microscopy
 
Cells (TDY27 and derivatives) were grown in YPD to A
 
600
 
 of 0.5, and pre-
shifted to nonpermissive temperature (38
 
8
 
C) for 15 min. After a 5-min
treatment with or without cycloheximide (10 
 
m
 
g/
 
m
 
l final concentration) the
cells were challenged with rapamycin (0.2 
 
m
 
g/ml final concentration) or
mock solution and incubated at 38
 
8
 
C for an additional 80 min. Further ma-
nipulation was essentially as previously described (Yuan et al., 1999). In
brief, Cells were washed twice with distilled water, resuspended in 1.5%
potassium permanganate solution and incubated at room temperature for
20 min. The specimens were dehydrated by washing with increasing con-
centrations of ethanol, followed by two washes with 100% propylene ox-
ide. The cells were then infiltrated with a 50:50 mix of propylene oxide and
POLY/BED 812 (Polysciences, Inc.) for 2 d. The preparations were dried
in vacuum overnight, infiltrated with 100% POLY/BED with accelerator
2,4,6-Tri(dimethylaminomethyl) phenol (DMP-30, Polysciences, Inc.) for
 
another 2 d, and then incubated in an oven overnight at 60
 
8
 
C. The result-
ing samples were mounted on blocks, sectioned, and prepared for exami-
nation on a JEOL 100CX II transmission electron microscope.
 
Results
 
The Rapamycin-induced Bypass of the prAPI 
Trafficking Defect in vac8
 
D
 
 Cells Occurs in the 
Presence of Cycloheximide
 
We were interested in understanding whether rapamycin-
dependent effects on transcription and translation had a
central role in the induction of autophagy. Several meth-
ods for assaying autophagy exist. One may observe the ul-
trastructural result of autophagy, namely the accumulation
of intravacuolar autophagic bodies in the presence of
PMSF or in a 
 
pep4
 
 mutant (Takeshige et al., 1992). This
method has the disadvantage of not being easily quantifi-
able. Another method is to follow the formation of active
alkaline phosphatase from Pho8
 
D
 
60p, a cytoplasmic vari-
ant of the vacuolar Pho8 protein that is imported into the
vacuole and activated upon induction of autophagy (Noda
et al., 1995). However, this approach turned out to be
problematic. The baseline (constitutive) alkaline phos-
phatase activity of cells expressing Pho8
 
D
 
60p decreased in
the presence of cycloheximide and this made it difficult to
interpret the meaning of fold changes upon induction of
autophagy. It has recently been demonstrated that under
conditions where prAPI trafficking is blocked in a Cvt-
pathway specific fashion, one can observe maturation of
prAPI upon induction of autophagy by rapamycin (Abe-
liovich et al., 1999), and that this maturation is a mea-
sure of autophagosome formation. Indeed, in contrast to
Pho8
 
D
 
60p, the prAPI that is accumulated in Cvt pathway-
specific mutants is stable over the time course of these ex-
periments. We therefore analyzed the ability of rapamycin
to bypass the 
 
vac8
 
D
 
 API trafficking defect in the presence
and absence of cycloheximide.
The 
 
vac8
 
D
 
 mutant accumulates prAPI when grown in
SD medium (Wang et al., 1998; Scott et al., 2000; and Fig.
1). However, 
 
vac8
 
D
 
 yeast are not defective in autophagy
(Wang et al., 1998; Scott et al., 2000). As a result, prAPI is
delivered to the vacuole and matured when cells are
shifted to starvation conditions or when autophagy is
induced by treatment with rapamycin (Fig. 1 A). To
determine whether protein synthesis was required for this
bypass mechanism, 
 
vac8
 
D
 
 cells were treated with cyclo-
 
Table I. S. cerevisiae Strains Used in This Study 
 
Strain Genotype Reference or Source
 
SEY6210 
 
MAT
 
a
 
 leu2-3,112 ura3-52 his3-
 
D
 
200 trp1-
 
D
 
901 lys2-801 suc2-
 
D
 
9
 
Robinson et al
 
.
 
, 1988
D3Y101 SEY6210 
 
apg13
 
D
 
::LEU2 
 
Scott et al
 
., 
 
2000
WPHYD2 SEY6210 
 
aut2
 
D
 
::LEU2 
 
Huang et al., 2000
WPHYD7 SEY6210 
 
aut7
 
D
 
::LEU2 
 
Huang et al., 2000
THY119 SEY6210 
 
cvt3-1
 
  Harding et al., 1995
HAY394 SEY6210 
 
vac8
 
D
 
:: TRP1
 
 This  study
HAY395 SEY6210 
 
apg1
 
D
 
::URA3 
 
This study
TDY27 SEY6210 
 
vam3ts 
 
Abeliovich et al
 
.
 
, 1999
TVY1 SEY6210 
 
pep4
 
D
 
::LEU2
 
  Gerhardt et al., 1998
HAY382 TDY27 
 
vac8
 
D
 
:: TRP1
 
 This  study
HAY398 TDY27 
 
aut7
 
D
 
::HIS5
 
 S.p.  This study 
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heximide for 5 min before addition of rapamycin. Treat-
ment with rapamycin in the presence of cycloheximide still
allowed bypass of the 
 
vac8
 
D
 
 defect. Cycloheximide alone
did not support bypass of the 
 
vac8
 
D
 
 defect, indicating that
the bypass is specific to rapamycin (see also Noda and
Ohsumi, 1998). Identical results were seen with 
 
cvt9
 
D
 
 cells
indicating that this reversal is not specific to the 
 
vac8
 
D
 
 mu-
tation (data not shown). Administration of cycloheximide
five minutes before labeling resulted in a 
 
.
 
98% block in
protein synthesis and nondetectable levels of radiolabeled
API (Fig. 1 A, control). In contrast, neither rapamycin nor
cycloheximide had any effect on the prAPI trafficking de-
fect of 
 
vac8
 
D
 
 vam3
 
ts
 
 double mutant cells at the nonpermis-
sive temperature, or on 
 
apg1
 
D
 
 cells, which are defective in
both the Cvt pathway and in autophagy. These results in-
dicate that the rapamycin-induced bypass is dependent on
autophagy and does not require bulk protein synthesis.
 
Cycloheximide Blocks Rapamycin-dependent Induction 
of API and Aut7p
 
Our pulse-chase experiments reveal that a block in protein
synthesis does not inhibit autophagic delivery of prAPI to
the vacuole. It is still possible that specific proteins in-
volved in autophagy are accumulated in spite of the global
block to translation. We therefore addressed whether
treatment with cycloheximide under these conditions
blocked the induction of proteins that are specifically up-
regulated by rapamycin. As shown in Fig. 1 B, the levels of
both API and Aut7p were strongly induced by rapamycin,
in agreement with previous reports (Scott et al., 1996;
Hardwick et al., 1999; Kirisako et al., 1999; Huang et al.,
2000). In the presence of 10 
 
m
 
g/ml cycloheximide, how-
ever, neither protein was induced by rapamycin. In fact,
Aut7p, which is depleted by its transport into the vacuole,
was clearly reduced in abundance as a result of treatment
with cycloheximide. Likewise, we observed depletion of
prAPI in the presence of cycloheximide as a result of its
transport into the vacuole and processing to the mature
form. We can therefore conclude that even specific, upreg-
ulatable proteins are not induced by rapamycin in the
presence of cycloheximide.
 
Cycloheximide Does Not Block Apg1p-independent 
Dephosphorylation of Apg13p
 
The experiments shown in Fig. 1 strongly suggest that
a specific signal transduction mechanism directly alters
membrane trafficking patterns in response to rapamycin,
independent of the change in gene expression pattern. We
sought to identify a potential link in such a mechanism.
Apg1p is a protein kinase required for both autophagy and
the Cvt pathway (Scott et al., 1996; Matsuura et al., 1997).
Overexpression of Apg1p can bypass the autophagy defect
that results from loss of Apg13p (Funakoshi et al., 1997),
and the two proteins have been shown to interact in two-
hybrid experiments (Uetz et al., 2000). In addition, it is
known that Apg13p, a phosphoprotein, is dephosphory-
lated in response to starvation cues and this dephosphory-
lation can be monitored as an increase in electrophoretic
mobility (Kamada et al., 2000; Scott et al., 2000). We ex-
amined whether Apg13p undergoes its normal dephos-
phorylation response when protein synthesis is inhibited
by cycloheximide. As shown in Fig. 2 A, an increase in mo-
bility indicative of dephosphorylation clearly occurred in
cells treated with both rapamycin and cycloheximide. This
stands in contrast with the effects, in the same experiment,
on the levels of API: as in the previous experiment (Fig. 1
B), API was induced with rapamycin, but this induction
was blocked by cycloheximide. Thus, dephosphorylation
of Apg13p is a potential signal mechanism for autophagy,
and occurs independent of de novo protein synthesis. If
Apg13p is a downstream effector of Apg1p, dephosphory-
lation of Apg13p would not take place upon treatment of
Figure 1. A, Rapamycin-induced bypass of the vac8D prAPI
trafficking block occurs in the presence of cycloheximide. Dele-
tion mutants (vac8D, HAY394; apg1D, HAY395) were grown
overnight at 308C and pulse-labeled for 10 min with 35S-labeled
cysteine and methionine. Chase solution was added, followed
by addition of cycloheximide to 40 mg/ml in SD medium, or
mock SD medium to the same volume. After a 5-min incuba-
tion, the cultures were diluted fourfold with SD medium con-
taining rapamycin (0.2 mg/ml final concentration, diluted from
a 1 mg/ml stock in 90% ethanol/10% Tween-20) or SD medium
alone. Samples (2 A600 equivalents) were removed at 0, 1, and
2 h after addition of rapamycin. HAY382 cells (vac8D vam3ts)
were grown overnight at 268C and shifted to 388C for 15 min
before labeling and treatment as above. Control lane: cells
were treated as above except that cycloheximide was added 5
min before the addition of label for 10 min, followed by chase,
processing, and immunoprecipitation as above. B, Cyclohexim-
ide blocks specific induction of API and Aut7p by rapamycin.
Wild-type (SEY6210) cells were grown to an A600 of 0.6. They
were treated with or without cycloheximide (10 mg/ml from a
50 mg/ml stock in ethanol) for 5 min before administration of
rapamycin (2 mg/ml final concentration) or mock drug vehicle
to the same volume. The cultures were further incubated for
2 h, precipitated with 10% TCA, and processed for Western
blotting as described in Materials and Methods. 20 mg protein
were loaded per lane and blots were probed for API. 
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apg1
 
D cells with rapamycin. We found however, that
apg1D cells underwent normal dephosphorylation of
Apg13p under these conditions (Fig. 2 B), indicating that
dephosphorylation of Apg13p may be an upstream event
that regulates Apg1p activation.
Protein Synthesis Is Required to Sustain Formation of 
Normal Sized Autophagosomes
While our data indicate that induction of autophagy does
not require protein synthesis, the degree of rapamycin-
dependent rescue of the vac8D defect is slightly attenuated
in the presence of cycloheximide (Fig. 1). Quantitative analy-
sis revealed that at the 2 h time point, an average of 78%
of prAPI was matured in the absence of cycloheximide
and only 52% in the presence of cycloheximide (n = 2). In
the absence of protein synthesis the existing amounts of
Aut7p and perhaps other upregulated Apg proteins are
quickly depleted (Fig. 1 B), and there are two possible out-
comes. In one, normal autophagosomes are formed, but
their numbers are lower, due to the limiting amounts of
specific Apg proteins. An alternative hypothesis is that nu-
cleation of autophagosome formation occurs independent
of messenger RNA translation, but that the expansion of
the engulfing autophagic membrane is dependent on new
protein synthesis, and as a result the autophagosomes that
form in the presence of cycloheximide will be smaller or
otherwise misshapen. To distinguish these possibilities, we
performed EM analysis of autophagosome formation in
vam3ts cells in the presence and absence of cycloheximide.
As previously shown, vam3ts cells incubated at the non-
permissive temperature accumulated cytoplasmic autopha-
gosomes when challenged with rapamycin (Abeliovich et
al., 1999; Fig. 3). This is a result of the fact that Vam3p is
required for all characterized membrane fusion events at
the vacuolar periphery (Darsow et al., 1997). When induc-
tion of autophagy by rapamycin was done in the presence
of cycloheximide, the average size of autophagosomes de-
creased from 400–500 nm diameter in control cells, to 100–
200 nm diameter in cycloheximide pretreated cells (Fig. 3
Figure 2. Cycloheximide does
not block a rapamycin-induced,
Apg1p-independent dephosphor-
ylation of Apg13p. A, D3Y101
cells (apg13D) cells harboring
plasmid YEp351[APG13] were
grown in SD medium to A600 of
0.6 and treated with or without
cycloheximide (10 mg/ml final
concentration) for 5 min before
administration of rapamycin (0.2
mg/ml final concentration). Cells
were incubated for 2 h, treated
with 10% TCA, and cell extracts
were prepared for Western blot-
ting as above. Blots were probed
with specific antisera for Apg13p
and API by Western blotting. B,
Wild-type and apg1D cells har-
boring plasmid YEp351[APG13]
were grown in SD and treated
with or without rapamycin for 2 h
before processing as above.
Figure 3. Induction of autophagosomes in the presence of cy-
cloheximide results in the accumulation of abnormally small
autophagosomes. TDY27 (A–F; vam3ts) or TVY1 (G and H;
pep4D) yeast were grown to A600 of 0.5 at 268C (TDY27) or
308C (TVY1) and shifted to 388C for 15 min (TDY27) or di-
rectly processed at 308C (TVY1). The cells were then treated
with or without cycloheximide (10 mg/ml final concentration)
for 5 min before addition of rapamycin (0.2 mg/ml final con-
centration) or mock drug vehicle. Cells were incubated a fur-
ther 1.5 h at 388C before permanganate fixation for EM as
described in Materials and Methods. Arrows denote autopha-
gosomes and autophagic bodies, arrowheads identify the small
autophagosomes and autophagic bodies that are seen in cyclo-
heximide 1 rapamycin-treated cells. A and B, no treatment;
C, E, and G, rapamycin alone; D, F, and H, rapamycin 1 cy-
cloheximide. Bar, 1 mM. N, Nucleus; V, vacuole; m, mitochon-
dria.The Journal of Cell Biology, Volume 151, 2000 1030
A), while the number of autophagosomes was not sig-
nificantly altered. Cycloheximide alone did not induce
autophagosomes (data not shown, see also Noda and
Ohsumi, 1998). When we repeated this experiment using
pep4D cells, we found an accumulation of autophagic bod-
ies in the vacuole, as expected since these cells are unable
to break down components that reach the vacuole. Again,
these autophagic bodies that accumulated in the vacuole
after cycloheximide treatment were smaller than normal
(Fig. 3 B). This result indicates that new protein synthesis,
perhaps of Aut7p or other proteins as well, is required for
the expansion of the autophagic membrane, while a sepa-
rate signal transduction event is responsible for the initial
nucleation of autophagosomal membranes.
These effects of cycloheximide suggest a specific re-
quirement for protein synthesis in autophagosome expan-
sion and morphology. To substantiate this possibility, we
tested whether deletion of AUT7, a gene whose product is
upregulated by rapamycin, results in the formation of ab-
errantly shaped autophagosomes in the vam3ts genetic
background. The ability of aut7D cells to induce autopha-
gosomes has been a point of some confusion in the litera-
ture (Lang et al., 1998; Kirisako et al., 1999). We treated
mutant aut7D vam3ts cells with or without rapamycin and
cycloheximide at nonpermissive temperature and ana-
lyzed them by EM, as above. As shown in Fig. 4, B and D,
these cells indeed accumulated small cytoplasmic autopha-
gosomes in response to rapamycin. These small autopha-
gosomes are reminiscent of those observed for vam3ts cells
in the presence of cycloheximide (see Fig. 3) although
their numbers appeared diminished relative to the vam3ts
background (0.62 6 0.7 autophagosomes per slice versus
1.9 6 1 autophagosomes per slice). When aut7D vam3ts
cells were treated with rapamycin in the presence of cyclo-
heximide, they also induced small aberrantly shaped au-
tophagosomes (Fig. 4 C). Thus, cells lacking Aut7p show
changes in membrane dynamics in response to rapamycin
both in the presence and in the absence of cycloheximide,
again indicating that a signal transduction event is being
triggered independently of mRNA translation or indeed
of Aut7p itself.
If deletion of AUT7 results in aberrant autophagocyto-
sis as opposed to its complete abrogation, then aut7D cells
should show some degree of prAPI maturation upon in-
duction of autophagy, in contrast to mutants defective in
the nucleation step, such as apg1D (see Fig. 1). We find
that aut7D cells incubated in SD-N mature significant
amounts of prAPI (Fig. 5 A), confirming that these cells
have a capacity to form complete autophagosomes.
Susceptibility to Nitrogen Starvation Is Inversely 
Correlated with Rescue of Cvt Phenotypes
by Autophagy
If all APG proteins were equally required for autophagy,
and autophagy is essential for survival upon starvation,
one expects deletion mutants to display similar degrees of
loss of viability under nitrogen starvation. However, a
known yet unexplained phenomenon is that different apg
mutants show different degrees of survival under these
conditions. One may hypothesize, based on our results,
that mutants defective in autophagosome nucleation will
show dramatically lower viability in nitrogen starvation
Figure 4. Induction of aberrantly shaped autophagosomes occurs
in aut7D vam3ts cells upon treatment with rapamycin. EM analy-
sis of HAY398 cells (aut7D vam3ts) after rapamycin treatment at
nonpermissive temperature. Yeast were grown overnight at 268C
to A600 of 0.5 and shifted to 388C for 15 min. The cells were then
treated with or without cycloheximide (10 mg/ml final concentra-
tion) for 5 min before addition of rapamycin (0.2 mg/ml final con-
centration) or mock drug vehicle. Cells were incubated a further
1.5 h at 388C before permanganate fixation for EM as described
in Materials and Methods. A, no treatment; B and D, rapamycin;
C, rapamycin 1 cycloheximide. Arrowheads denote the small au-
tophagosomes visualized in these cells. Bar, 1 mM. N, Nucleus; V,
vacuole; m, mitochondria.
Figure 5. The Cvt bypass
phenotype is correlated with
partial survival under nitro-
gen starvation conditions. A,
Immunoblots of prAPI
maturation in nitrogen star-
vation  medium. SEY6210
(wild-type), THY119 (cvt3),
WPHYD7 (aut7D), WPHYD2
(aut2D), and HAY395 (apg1D)
strains were grown to midlog
phase and shifted to SD-N
medium for 0, 1, 2, 4, and 6 h.
At each time point, 3 A600
units of cells were precipi-
tated in 10% TCA, washed
twice with acetone, and pro-
cessed for Western blotting as
described in Materials and
Methods. B, Viability of yeast
strains in nitrogen starvation
medium. SEY6210 (wild-type),
THY119 (cvt3), WPHYD7
(aut7D), WPHYD2 (aut2D), and HAY395 (apg1D) strains were
grown to midlog phase in SMD and transferred to SD-N medium.
Aliquots were removed at the indicated times and spread onto
YPD plates in triplicate. The number of colonies was counted after
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medium, and should not allow autophagy-mediated bypass
of the associated Cvt defects. On the other hand, mutants
that affect autophagosome expansion should allow some
degree of bypass, and show some viability in nitrogen star-
vation medium. As shown in Fig. 5 we indeed observed the
predicted relationship between viability and Cvt bypass in
SD-N medium. Loss of Apg1p could not be bypassed by
induction of autophagy, whether with rapamycin (Fig. 1)
or SD-N (Fig. 5 A). This, according to our criteria, implies
an involvement at the nucleation/signaling step. Indeed,
apg1D cells rapidly lost viability upon transfer to SD-N
(half-life of two days). Loss of Aut7p, on the other hand,
was correlated with a partial bypass of the Cvt phenotype
(Fig. 5 A). This implies, by our criteria, a requirement for
this protein at the expansion step. Indeed, aut7D cells were
much less sensitive to nitrogen starvation (half-life of five
to six days). This last result mirrors the ability of these
cells to accumulate autophagosomes in the vam3ts back-
ground, as demonstrated by EM analysis in Fig. 4. Dele-
tion of Aut2p, a protein that is required for Aut7p func-
tion (J. Kim, W.-P. Huang, and D.J. Klionsky, manuscript
submitted for publication) resulted in a phenotype similar
to that of aut7D for both traits (Fig. 5). Similarly, a cvt3
mutant, which is known to be defective in Cvt trafficking,
but not for autophagy (Scott et al., 1996) was highly resis-
tant to starvation and matured prAPI in SD-N. These re-
sults are again consistent with a view of autophagosome
formation as a multistep process, consisting minimally of a
nucleation step and an expansion step. Defects in the nu-
cleation step completely abrogate the process, whereas de-
fects in expansion merely attenuate it such that it becomes
physiologically ineffective.
Discussion
Autophagy is a catabolic membrane trafficking event that
is essential for the survival of yeast under conditions of nu-
trient limitation. The general mechanistic outline of au-
tophagy is known (Klionsky and Ohsumi, 1999; Kim and
Klionsky, 2000). However, important points still remain to
be established. In this report, we have approached the is-
sue of whether autophagy is induced by a dedicated signal
transduction mechanism or as a byproduct of changes in
gene expression patterns upon starvation.
Autophagy Is Induced Independently of De Novo 
Protein Synthesis
Current knowledge of signal transduction mechanisms
that impinge on gene expression is extensive. Signaling
pathways in which membrane homeostasis is perturbed di-
rectly, and not as a result of other events, are not as well
characterized. As we now show, the harnessing of the Cvt
pathway machinery to initiate bulk macroautophagy is in-
dependent of changes in gene expression. While our data
clearly show that a regulatory “switch” exists between the
Cvt state and the autophagic state of the system, we can-
not surmise that changes in gene expression are altogether
physiologically unimportant for autophagy. Rather, we
suggest that while the regulatory “switch” controls the
trafficking pattern, changes in gene expression, namely
upregulation of proteins such as Aut7p, are important in
determining the amplitude of the response. This picture is
analogous to a railroad track switch, which, independently
of the number of cars on the train, will shunt the engine
into one track or the other while the capacity of the path-
way for cargo is determined elsewhere. Consistent with
this view, we find that autophagosomes that are formed in
the absence of protein synthesis are significantly smaller
than normal, as are autophagosomes formed in the ab-
sence of Aut7p. The fact that we are able to achieve the
same type of uncoupling between nucleation and expan-
sion with both genetic and chemical intervention implies
that the two steps are mechanistically distinct.
Aut7p Function Is Required for Proper Autophagosome 
Size and Structure
Our findings discern between an initial nucleation stage
and a secondary, Aut7p-dependent expansion stage, both
of which apparently precede the final closure of the au-
tophagosome. Cells that lack Aut7p function closely
mimic cells that are treated with cycloheximide in terms of
the size of the autophagosomes that they accumulate in
the vam3ts background. As Aut7p is upregulated in re-
sponse to rapamycin and starvation, this consolidates our
initial observation (Fig. 3) of de novo protein synthesis
being specifically required only for autophagosome ex-
pansion. The fact that the number of autophagosomes
that accumulate in aut7D cells is somewhat reduced may
indicate some redundant or indirect effect on autophago-
some nucleation in these cells. On the other hand auto-
phagosome expansion in these cells is absolutely blocked,
indicating a central role for Aut7p in this step of the pro-
cess.
Aut7p was originally suggested to function in the teth-
ering of autophagosomes to microtubules, and observa-
tions of cytoplasmic autophagosomes in aut7D cells were
reported (Lang et al., 1998). Later studies contested this,
and reported that no autophagosomes are observed in
aut7D mutants (Kirisako et al., 1999), but did discuss the
observation of aberrant, autophagosome-like structures in
SD-N. Intriguingly, the autophagosomes that were seen in
aut7D cells in the initial report (Lang et al., 1998) were sig-
nificantly smaller (100–200 nm diameter) than normal-
sized autophagosomes (300–900 nm diameter, see Fig. 4),
consistent with our results. Clearly, one major difference
between our study and previous efforts is the use of the
vam3ts background. This allows us to quantify the auto-
phagosome-forming capacity of these cells, whereas in a
wild-type background these autophagosomes will largely
be degraded in the vacuole and not be accumulated in the
cytoplasm.
Our functional designation of Aut7p as required for au-
tophagosome expansion reconciles these opposing obser-
vations, but also integrates other data into our understand-
ing of these processes: Aut7p function in yeast has recently
been shown to involve SNARE (soluble N-ethylmaleim-
ide–sensitive factor attachment protein receptor) interac-
tions (Legesse-Miller et al., 2000). Thus, it is plausible that
the Aut7p-dependent membrane expansion step in au-
tophagosome biogenesis reflects SNARE protein involve-
ment at this point in the process. This view also concurs
with the known requirement for SNARE proteins in the
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Defects in Autophagosome Expansion Explain the 
Existence of Autophagy Mutants that Are Partially 
Sensitive to Nitrogen Starvation
We observe abnormally small autophagosomes upon in-
duction of autophagy in the absence of protein synthesis
and in aut7D vam3ts cells. Such small autophagosomes can
be predicted to be inefficient at supporting the physiologi-
cal role required of them under starvation conditions as
the total volume of cytoplasm that they carry is limited. In
addition, they appear to have gone undetected in previous
light microscopy studies. The existence of proteins that
specifically function to enlarge the autophagosome may
explain yet other observations: deletion mutants of dif-
ferent APG genes show varying degrees of sensitivity to
starvation. Some of the relatively starvation-resistant mu-
tants may, like aut7D, produce abnormal autophagosomes,
whereas the more starvation-sensitive mutants, such as
apg1D, form no autophagosomes. Here, we have con-
firmed that such a classification of apg mutants exists, and
fits the expected inverse relationship between Cvt bypass
and nitrogen starvation sensitivity. Mutants defective in
Aut7p and Aut2p function show longer survival times un-
der nitrogen starvation relative to apg1D cells, though they
are not as resistant as wild-type or cvt3-1 cells (Fig. 5 B).
On the other hand they show some bypass of the API traf-
ficking defect when autophagy is induced, much like cvt3-1
cells (Fig. 5 B). This bypass is wholly in agreement with
the fact that aut7D vam3ts double mutant cells accumulate
small cytoplasmic autophagosomes when challenged with
rapamycin at the nonpermissive temperature, although
some involvement of microautophagy cannot be ruled out.
Induction of Autophagy Is Regulated through Protein 
Phosphorylation and Dephosphorylation
The molecular control mechanism that determines whether
a cell chooses Cvt or autophagic trafficking is linked to
Tor activity. It has recently been shown that changes in
phosphorylation of Apg13p are correlated with induction
of autophagy (Scott et al., 2000). We now show that the
dephosphorylation of Apg13p conforms to at least one cri-
terion for being part of the postulated signal transduction
pathway in that it is not dependent on new protein synthe-
sis. Since Apg13p functionally interacts with the protein
kinase Apg1p (Funakoshi et al., 1997), and in light of the
fact that phosphorylation/dephosphorylation of Apg13p is
not dependent on Apg1p, it is tempting to speculate that
Apg13p is modulating Apg1p function in response to
changes in Tor activity. This conclusion concurs with a re-
cent report (Kamada et al., 2000). These authors used an
in vitro kinase assay to show that the Apg13p–Apg1p in-
teraction modulates Apg1p kinase activity and that this
interaction is itself modulated in response to rapamycin.
Our results further elaborate on this finding in demon-
strating that the rapamycin-dependent dephosphorylation
of Apg13p does not require Apg1p activity. Taken to-
gether, these studies establish that dephosphorylation of
Apg13p is a bona fide control event for Apg1p activity. In
addition to its interaction with Apg1p, Apg13p has been
demonstrated to interact with Vac8p. Since the latter is
not required for autophagy, we speculate that Apg1p is a
catalytic subunit of two alternative holoenzymes that di-
rect either the formation of Cvt vesicles (using Cvt9p and
perhaps Vac8p as regulatory subunits) or autophagy (us-
ing Apg13p and Apg17p as regulatory subunits). Support
for this hypothesis must now come from detailed studies of
the possible protein complexes in which Apg1p partici-
pates and analysis of their different activities.
Rapamycin induces autophagy in higher eukaryotic cells
(Cutler et al., 1999; Shigemitsu, et al., 1999), and a number
of APG genes have been found to have mammalian homo-
logues (Mizushima et al., 1998; Sagiv et al., 2000). There-
fore, it is possible that this dedicated autophagic signal
transduction mechanism is conserved as well. We suggest
that our data can be explained by the following model
(Fig. 6): under normal growth conditions, Tor activity pre-
vents dephosphorylation of Apg13p. Inhibition of Tor by
the rapamycin–FKBP complex results in the dephosphory-
lation of Apg13p, leading to an Apg1p-dependent auto-
phagosome nucleation event. In parallel, inhibition of Tor
results in changes in gene expression (Beck and Hall, 1999;
Cardenas et al., 1999; Hardwick et al., 1999). As a result,
the levels of Aut7p, and perhaps other proteins, are in-
creased and these proteins function in the expansion of au-
tophagosomes to their normal size and shape.
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Figure 6. Model for induction of autophagy by rapamycin. Tor
activity prevents dephosphorylation of Apg13p, by an unknown
mechanism. Inhibition of Tor by the rapamycin–RBP complex
then results in rapid dephosphorylation of Apg13p. Dephosphor-
ylated Apg13p acts on Apg1p to mediate autophagosome nucle-
ation. In the absence of new protein synthesis, this results in
abnormally small autophagosomes. Under normal conditions,
however, inhibition of Tor also upregulates the transcription of
starvation- and autophagy-specific genes, and the ensuing in-
crease in levels of specific proteins, such as Aut7p, allows the ex-
pansion of autophagosomes.Abeliovich et al. Separate Nucleation and Expansion Steps in Autophagy 1033
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